Helicobacter pylori (Hp) is a major cause of chronic-active gastritis, primary duodenal ulcers and strongly linked to gastric cancer. Most Hp infections worldwide are acquired in childhood. Why some individuals develop symptomatic disease is unclear and, until recently, no studies critically evaluated the role of pediatric Hp strains and/or host factors in disease outcomes. Over the past 5 years of NIH funding, 486 children from Atlanta, Cleveland, and Miami were enrolled; 184 (38%) were Hp-infected. Race (African American) and younger age, in conjunction with Hp strains expressing cagA and vacAs1 B, were shown to be risk factors for both esophageal and gastric disease; suggesting a different disease paradigm from Hp-infected adults. Using the Updated Sydney system, we demonstrated a histopathologic spectrum in children, which included novel observations of atrophic gastritis with intestinal metaplasia. Overall hypothesis for competitive renewal: disease manifestations in Hp-infected children are influenced by specific host factors (i.e., race, immune phenotype), environmental exposures, and specific virulence factors of infecting Hp strains.
Specific aims : 1) Using well defined cases and controls, further characterize specific host factors and environmental exposures contributing to symptomatic childhood infection emphasizing targeted enrollment in specific age, gender and demographic strata to facilitate detection of significant differences not attained previously and follow up of 2 established specific cohorts to ascertain immune response natural history. 2) Utilize gene-array technology for whole Hp genome assessment and bacterial gene expression of specific virulence determinants associated with pediatric Hp strains. 3) Further, characterize the host immunologic and mucosal response in Hp infected children. Hp-infected symptomatic endoscopy cases at our established three clinical centers of high, moderate and low tip prevalence will be compared with age-matched Hp-infected asymptomatic and uninfected symptomatic controls. Two geographically and demographically distinct centers have been added to provide additional geographic and subject representativeness to the patient cohort. The Updated Sydney system will be employed to assess gastric histopathology severity and phenotype in newly enrolled cases in specific age, gender and demographic strata and follow-up of the two """"""""novel"""""""" cohorts established in the past 5 years; a) atrophic gastritis; b) esophageal and gastric disease group enabling a comprehensive, multivariate evaluation of the natural history of Hp-infected children in two distinct disease paradigms. Using molecular methods (multiplex [MP]-PCR, RT-PCR) and a micro ELISPOT assay on peripheral blood mononuclear cells (PBMCS), Th1, Th2, Th3 or balanced Th1/Th2 response will be determined to further characterize the Hp-infected child's immune response phenotype. We propose to further our previous work with critically lacking studies from a multivariate approach leading to a better understanding of the gastroduodenal disease sequelae and overall pathobiology of Hp infection in humans.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK053708-07
Application #
6943174
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Robuck, Patricia R
Project Start
1997-09-30
Project End
2007-05-31
Budget Start
2005-06-01
Budget End
2006-05-31
Support Year
7
Fiscal Year
2005
Total Cost
$402,649
Indirect Cost
Name
Emory University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Gupta, Neera; Bostrom, Alan G; Kirschner, Barbara S et al. (2010) Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients. Inflamm Bowel Dis 16:638-44
Jose, Folashade Adebisi; Garnett, Elizabeth A; Vittinghoff, Eric et al. (2009) Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 15:63-8
Sherman, Philip M; Hassall, Eric; Fagundes-Neto, Ulysses et al. (2009) A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol 104:1278-95; quiz 1296
Talarico, Sarah; Gold, Benjamin D; Fero, Jutta et al. (2009) Pediatric Helicobacter pylori isolates display distinct gene coding capacities and virulence gene marker profiles. J Clin Microbiol 47:1680-8
Nurgalieva, Zhannat; Goodman, Karen J; Phillips, Carl V et al. (2008) Correspondence between Helicobacter pylori antibodies and urea breath test results in a US-Mexico birth cohort. Paediatr Perinat Epidemiol 22:302-12
White, Jolanda M; O'Connor, Siobhan; Winter, Harland S et al. (2008) Inflammatory bowel disease in African American children compared with other racial/ethnic groups in a multicenter registry. Clin Gastroenterol Hepatol 6:1361-9
Gupta, Neera; Bostrom, Alan G; Kirschner, Barbara S et al. (2008) Presentation and disease course in early- compared to later-onset pediatric Crohn's disease. Am J Gastroenterol 103:2092-8
Humbert, Olivier; Salama, Nina R (2008) The Helicobacter pylori HpyAXII restriction-modification system limits exogenous DNA uptake by targeting GTAC sites but shows asymmetric conservation of the DNA methyltransferase and restriction endonuclease components. Nucleic Acids Res 36:6893-906
Gupta, Neera; Bostrom, Alan G; Kirschner, Barbara S et al. (2007) Gender differences in presentation and course of disease in pediatric patients with Crohn disease. Pediatrics 120:e1418-25
Minohara, Yutaka; Boyd, David K; Hawkins, Hal K et al. (2007) The effect of the cag pathogenicity island on binding of Helicobacter pylori to gastric epithelial cells and the subsequent induction of apoptosis. Helicobacter 12:583-90

Showing the most recent 10 out of 32 publications